SCHEMBL32687973

SCHEMBL32687973

CCOC(=O)c1c(-c2cccc(C(=O)N(C)c3ccccc3)c2)c(C#N)c(S)[nH]c1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.48
▸ HTT P42858 1/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.48
▸ RXFP1 Q9HBX9 1/20 0.48
▸ TP53 P04637 2/20 0.45
▸ CSF1R P07333 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ MAP3K5 Q99683 1/20 0.42
▸ TSHR P16473 1/20 0.39
▸ MAPT P10636 3/20 0.39
▸ LMNA P02545 2/20 0.39
▸ KMT2A Q03164 4/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ GLA P06280 1/20 0.38
▸ ATM Q13315 1/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688220 0.86 HSD17B2 (0.39) ALDH1A1HTTNPSR1TP53TSHR
SCHEMBL32688244 0.86 ALDH1A1 (0.55) ALDH1A1HTTNPSR1RXFP1CSF1R
SCHEMBL32688181 0.75 ALDH1A1 (0.65) ALDH1A1HTTNPSR1RXFP1TP53
SCHEMBL32688045 0.71 ACMSD (0.46) ALDH1A1HTTNPSR1RXFP1TP53
SCHEMBL32688402 0.71 POLB (0.49) ALDH1A1MAPTKMT2AMEN1HPGD
SCHEMBL32687975 0.67 KDM4E (0.47) ALDH1A1HTTNPSR1RXFP1KMT2A
SCHEMBL26664883 0.66 ALDH1A1 (0.55) ALDH1A1HTTNPSR1RXFP1CSF1R
SCHEMBL4373230 0.66 GRIA2 (0.58) KMT2A
SCHEMBL10379238 0.65 ALDH1A1 (1.00) ALDH1A1HTTNPSR1RXFP1TP53
SCHEMBL32688430 0.65 PDE9A (0.50) ALDH1A1RXFP1KMT2AKDM4EGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK ALDH1A1 290/4885HTT 2641/4885NPSR1 2673/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback